CBD, Genetics, Ketogenic Diet, Pediatric Epilepsy
A round-up of the top epilepsy research news from the past month.
Genetics, Pediatric Epilepsy
The authors claim that this study supports a mechanism in which loss of potassium SK channel activity causes the reticular thalamic neurons to become hyperexcitable and promote nonconvulsive seizures in Dravet syndrome.
CBD, Pediatric Epilepsy
Highly purified cannabidiol (CBD) at a dose of 10mg/kg/day can reduce convulsive seizures in children with Dravet syndrome by almost 50%, a study published in Neurology has found.
SUDEP
SUDEP Action claimed Education Team of the Year at the British Medical Journal (BMJ) Awards 2019.
Pediatric Epilepsy, SUDEP
Recent data suggest that febrile seizures may contribute to sudden unexplained death in childhood (SUDC) among cases of sudden explained death in childhood (SEDC).
Pediatric Epilepsy
Levetiracetam could be considered as an alternative treatment to phenytoin for second-line management of pediatric convulsive status epilepticus.
There are roughly as many autistic boys who have epilepsy as there are girls, according to a new meta-analysis.
Eisai Inc. presented the latest clinical results on FYCOMPA® (perampanel) CIII.
Ketogenic Diet
Although the ketogenic diet is the most effective dietary therapy for childhood drug-resistant epilepsy, the modified Atkins diet and low-glycemic index therapy are also effective, better tolerated, and less restrictive.
